Skip to main content

Friedman Paul A

In the past year, 3 open-market sale filings worth $26.7M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$26.7M
3 filings
Net
−$26.7M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Friedman Paul A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

MDGL Madrigal Pharmaceuticals, Inc.

Director9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 5, 2024 (view filing)Apr 3-52 daysFriedman Paul ADirectorSSale−73.7K$243.93−$18.0M−28.4%185.7K after20 lots10b5-1
Apr 10, 2024 (view filing)Apr 82 daysFriedman Paul ADirectorSSale−26.3K$246.19−$6.47M−12.4%185.7K after7 lots10b5-1
Jul 18, 2025 (view filing)Jul 16-172 daysFriedman Paul ADirectorSSale−28.9K$353.19−$10.2M−13.4%187.2K after9 lots10b5-1
Jul 22, 2025 (view filing)Jul 184 daysFriedman Paul ADirectorSSale−1.40K$350.03−$490.0K−0.7%187.2K after10b5-1
Aug 13, 2025 (view filing)Aug 11-122 daysFriedman Paul ADirectorSSale−46.8K$355.31−$16.6M−20.0%187.2K after12 lots10b5-1
Aug 13, 2025 (view filing)Aug 13Same dayFriedman Paul ADirectorSSale−129.2K$370.24−$47.8M−40.8%187.2K after17 lots10b5-1
Dec 12, 2025 (view filing)Dec 102 daysFriedman Paul ADirectorSSale−24.8K$552.18−$13.7M−11.7%187.2K after9 lots10b5-1
Jan 13, 2026 (view filing)Jan 94 daysFriedman Paul ADirectorSSale−24.5K$522.39−$12.8M−11.6%187.2K after28 lots10b5-1
Jan 13, 2026 (view filing)Jan 94 daysFriedman Paul ADirectorSSale−280$551.24−$154.3K−0.1%187.2K after10b5-1